ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

CircSCAP interacts with SF3A3 to inhibit the malignance of non-small cell lung cancer by activating p53 signaling

Chen, Dongni; Zhou, Hongli; Cai, Zhuochen; Cai, Kaican; Liu, Ji; Wang, Weidong; Miao, Huikai; Li, Hongmu; Li, Rongzhen; Li, Xiaodong; Chen, Youfang; Wang, Hui-Yun*; Wen, Zhesheng*南方医科大学; 中山大学
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH2022-4-1DOI: 10.1186/s13046-022-02299-0
10被引4阅读
引用收藏
分享

摘要

Background Circular RNA (circRNA) has been recently identified as a critical regulator during carcinogenesis. However, the biological function and potential underlying mechanisms of circRNAs in lung cancer remain to be further elucidated. Methods Here, we first evaluated the differentially expressed circRNAs between tumor and the matched adjacent nontumor tissues (3 pairs) of lung cancer patients via circRNA microarray. The expression of top five dysregulated circRNAs were tested in lung cancer cell lines and the circSCAP with concordant alteration in microarray data and cell lines was selected for further investigation. Then we validated the expression level of circSCAP in tumor and corresponding adjacent tissues (161 pairs) from a lung cancer cohort by RT-PCR analysis followed by correlation and prognosis analysis between circSCAP and clinical characteristics. Non-small cell lung cancer (NSCLC) accounts for the majority of lung cancer diagnosis (about 80% in the cohort used in this study). Therefore, we focused the role of circSCAP in NSCLC in the present study. In vitro and in vivo assays were performed to study the biological function of circSCAP in NSCLC. Biotin-labeled RNA pulldown and RNA immunoprecipitation (RIP) assays were carried out to identify the proteins directly interacting with circSCAP. The molecular mechanism of circSCAP-driven tumor suppression was demonstrated by immunoblotting, immunoprecipitation and luciferase reporter assays. In vitro and in vivo rescue experiments were conducted to verify the role of the circSCAP/SF3A3/p53 signaling axis in NSCLC. Results We screened the expression profiles of human circRNAs in lung cancer tissues and found that hsa_circ_0065214 (termed as circSCAP) was significantly decreased. Kaplan-Meier analysis showed that patients with low level of circSCAP had a significantly poor prognosis. Gain- and loss-of-function experiments suggested that circSCAP played an important role in NSCLC cell proliferation, cell migration and apoptosis. Mechanistically, circSCAP directly binds to the SF3A3 protein, facilitating the reduction of SF3A3 by promoting its ubiquitin-proteasome-mediated degradation, which enhances the expression of MDM4-S to finally activate its downstream p53 signaling. Conclusion These findings illustrate a novel circSCAP/SF3A3/p53 signaling axis involved in suppressing the malignance of NSCLC and provide a promising target for NSCLC prognosis prediction and treatment.

学科与关键词

关键词
Non-small cell lung cancerCircSCAPp53Prognosis
相关
加载中…
  • Insights Into circRNAs: Functional Roles in Lung Cancer Management and the Potential Mechanisms
    Feng, Bing; Zhou, Hao; Wang, Ting; Lin, Xinrong; Lai, Yongting; Chu, Xiaoyuan; Wang, Rui*Frontiers in Cell and Developmental Biology, 2021, 9: 636913.被引 6
  • CircFOXP1: A novel serum diagnostic biomarker for non-small cell lung cancer
    Luo, Yirong; Zhang, Qichao; Lv, Bo; Shang, Yanyan; Li, Juan; Yang, Lina; Yu, Zhiwu; Luo, Kai; Deng, Xiaoyan; Min, Ling; Zhu, Ting*INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2022, 37(1): 58-65.被引 8
  • circRNA_103615 contributes to tumor progression and cisplatin resistance in NSCLC by regulating ABCB1
    Liang, Hongguang; Lin, Zelong; Lin, Huiwen; Zhao, Li; Huang, Weihua*Experimental and Therapeutic Medicine, 2021, 22(3): 934.被引 6
查看全部 →

发表信息

论文状态
公开发表
期刊
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
发表日期
2022-04-01
卷期
第 41 卷, 第 1 期
页码
120
DOI
10.1186/s13046-022-02299-0
语言
ENGLISH
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81871986, 81772991]

作者

  • C

    Chen, Dongni (第一作者)

    sun yat sen univ · southern med univ

  • Z

    Zhou, Hongli

    sun yat sen univ

查看全部 13 位作者收起作者
  • C

    Cai, Zhuochen

    sun yat sen univ

  • C

    Cai, Kaican

    southern med univ

  • L

    Liu, Ji

    sun yat sen univ

  • W

    Wang, Weidong

    sun yat sen univ

  • M

    Miao, Huikai

    sun yat sen univ

  • L

    Li, Hongmu

    sun yat sen univ

  • L

    Li, Rongzhen

    sun yat sen univ

  • L

    Li, Xiaodong

    sun yat sen univ

  • C

    Chen, Youfang

    sun yat sen univ

  • W

    Wang, Hui-Yun (通讯)

    sun yat sen univ

  • W

    Wen, Zhesheng (通讯)

    sun yat sen univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417